Menopause is a transition.
Not the end of feeling like yourself.
Modern, evidence-based menopause care in Denver and Alamosa. Bioidentical hormone therapy, comprehensive labs, and clinical depth — for women who refuse to be told to "just deal with it."
WorldLink ABHRT certified · Lab-driven protocols · Ongoing monitoring
You don't have to suffer through this.
Menopause isn't a phase to endure — it's a profound hormonal shift that affects nearly every system in your body. The science around treatment has evolved dramatically over the past two decades. Most women who were told hormone therapy was "too risky" were given that advice based on a 2002 study that has since been substantially re-analyzed and revised. Modern evidence supports treatment for the right women, started at the right time, with the right approach.
What the data actually shows.
of women experience vasomotor symptoms (hot flashes, night sweats) during the menopausal transition
North American Menopause Society
reduction in vasomotor symptoms with appropriately prescribed hormone therapy
Modern HRT Effectiveness Data
FDA removed the black box warning from menopausal hormone therapy based on updated evidence
FDA Labeling Update, 2026
The end of cycles. Not the end of vitality.
Menopause is technically defined as a single point in time: the day you've gone 12 consecutive months without a menstrual period. The average age in the U.S. is 51-52, though the timing varies by individual genetics, lifestyle, and health factors.
The years leading up to that point are called perimenopause — the 4-10 year hormonal transition where most women first notice symptoms. After menopause itself, you're in postmenopause, which lasts the rest of your life.
While the cessation of menstruation marks the official transition, the underlying biological change is the dramatic decline of estrogen and progesterone. These hormones don't just regulate periods — they affect bone density, cardiovascular health, cognitive function, sleep architecture, mood regulation, joint health, vaginal and urogenital tissue, and overall metabolic function. Their decline is why menopausal symptoms span so many systems.
Where you are matters
Perimenopause
The 4-10 year transition. Periods irregular but still present. Often the most symptomatic phase. Learn more →
Menopause
12 consecutive months without a period. A single moment, retrospectively diagnosed. Average age: 51-52.
Early postmenopause
The first 5-10 years after menopause. Vasomotor symptoms often most active. The "window of opportunity" for HRT.
Late postmenopause
10+ years post-menopause. Different treatment considerations. Bone, cardiovascular, and urogenital health become primary focus.
Menopause affects nearly every system.
The decline in estrogen and progesterone isn't local — it ripples through every organ system. Most of these are highly treatable. None of them are "just aging."
Vasomotor & Sleep
- Hot flashes
- Night sweats
- Difficulty falling asleep
- Frequent night waking
- Waking unrefreshed
- Heart palpitations
- Temperature sensitivity
- Chills after hot flashes
Mood, Cognition & Energy
- Brain fog
- Word recall problems
- Anxiety or new "edge"
- Irritability
- Depression or low mood
- Low motivation
- Persistent fatigue
- Loss of confidence
Body, Bone & Metabolism
- Weight gain (especially abdominal)
- Muscle loss
- Joint pain & stiffness
- Bone density loss
- Hair thinning
- Skin dryness
- Vaginal dryness
- Painful intercourse
- Urinary urgency
- Recurrent UTIs
- Decreased libido
- Slower workout recovery
What the 2026 evidence actually says.
For more than two decades, women were told hormone therapy was "too risky" — based on the 2002 Women's Health Initiative (WHI) study. That study examined an older population (mostly women in their 60s and 70s, on average 12 years past menopause), used specific oral synthetic formulations, and reported findings that were widely generalized to all women, all formulations, and all delivery methods.
Subsequent re-analysis and decades of follow-up have substantially revised those conclusions.
Re-analyses of the WHI data show women aged 50-59 who started estrogen therapy had a 33% reduction in coronary heart disease and lower overall mortality. The 2026 FDA labeling update reflected this evolving evidence by removing the black box warning from menopausal hormone therapy products.
Modern protocols use bioidentical hormones (chemically identical to what your body makes) delivered through transdermal patches, creams, pellets, or other routes that bypass first-pass liver metabolism. The risk profile is meaningfully different from the older synthetic oral formulations studied in the original WHI trial.
The "window of opportunity."
One of the most important findings from modern research: the timing of hormone therapy initiation significantly affects the benefit-risk ratio. Earlier is generally better.
Under 60 years old, or within 10 years of menopause onset
For most women starting hormone therapy in this window, the evidence supports significant benefit with manageable risk. This is when HRT is most clearly indicated for symptom relief and long-term protective effects.
- Vasomotor symptom relief (75%+ reduction)
- Bone density preservation
- Cardiovascular benefit when started early
- Cognitive support during critical window
- Sleep, mood, libido restoration
Over 60 or more than 10 years past menopause
The risk-benefit calculation becomes more nuanced. HRT can still be appropriate for many women in this category, but evaluation requires more careful assessment of cardiovascular health, formulation choice (transdermal preferred), and individual goals.
- Transdermal preferred over oral routes
- Lower-dose protocols often appropriate
- More careful CVD risk evaluation
- Vaginal estrogen for genitourinary symptoms
- Decision-making more individualized
Multiple paths, tailored to you.
The "best" treatment depends on your specific symptoms, stage, health history, and goals. Most women benefit from some combination of these — designed and adjusted over time as your body changes.
Bioidentical Hormone Replacement (BHRT)
The most studied and effective treatment for menopausal symptoms. Bioidentical estrogen (estradiol) and progesterone — molecularly identical to what your body produced naturally — delivered through transdermal patches, creams, pellets, or oral capsules. Reduces vasomotor symptoms by up to 75%, supports bone, cardiovascular, and cognitive health.
Learn more about BHRTTestosterone Replacement for Women
Testosterone matters for postmenopausal women too — for libido, energy, mood, muscle preservation, and cognitive function. Many menopausal women have low testosterone alongside declining estrogen and progesterone. Low-dose testosterone is a meaningful clinical option that most clinics overlook entirely.
Learn about TRT for womenThyroid & adrenal optimization
Thyroid dysfunction often coexists with menopausal symptoms and amplifies them. We evaluate and treat these alongside sex hormones — because optimizing one without the others rarely produces the best result.
Learn about thyroid careVaginal estrogen for urogenital symptoms
Localized vaginal estrogen (cream, ring, or tablet) is highly effective for vaginal dryness, painful intercourse, and recurrent UTIs — with minimal systemic absorption. Appropriate for many women who can't or don't want systemic HRT, including some breast cancer survivors after careful evaluation.
See full hormone therapy approachHow we evaluate and treat menopause.
Defiance Health is a women-led practice with WorldLink ABHRT certified providers. Our approach is comprehensive, evidence-based, and oriented around your actual lived experience — not a one-size-fits-all protocol.
Comprehensive labs
Full hormone panel including estradiol, progesterone, FSH, LH, total and free testosterone, DHEA-S, full thyroid (TSH/T3/T4/Reverse T3/antibodies), cortisol, lipids, and metabolic markers.
Symptoms + data
Numbers don't tell the whole story. We treat your biology and your experience together — because identical lab values can produce very different lived experiences in different women.
Ongoing monitoring
Menopause isn't static. Hormone needs evolve. Regular follow-up labs and dose adjustments — not "set it and forget it." Your protocol changes with your body.
From first call to your treatment plan.
Schedule your comprehensive intake
Book online or call (719) 480-2400. Initial intake is $495 and includes your in-office lab draw, full hormone panel, and a 60-75 minute provider visit. Available in Centennial, Alamosa, or via telehealth in CO, AZ, CA, and WA.
Comprehensive labs & symptom mapping
We draw the full panel relevant to menopause — sex hormones, thyroid, adrenal, metabolic. We map your symptoms in detail and review your medical history. Lab results return in 5-7 days.
Lab review & treatment plan
You meet with your provider to review every result in plain language, discuss what's driving your symptoms, and review treatment options with clear pricing. You leave with a written plan.
Treatment initiation
If you choose to proceed, treatment typically begins within 1-2 weeks. We'll help you choose the right delivery method for your needs — patches, creams, pellets, or oral medication — and get you started.
Follow-up & ongoing care
First follow-up labs around 6-8 weeks. Adjustments based on how you feel and how labs respond. Long-term, you have ongoing access to your provider for questions and dose tuning. Your protocol evolves with your body.
Everything in one visit.
The first step is our comprehensive intake — designed to give you real answers in a single appointment.
Includes in-office lab draw, full menopause-relevant hormone panel, and a 60-75 minute provider visit to review your results and discuss treatment options. The fee is separate from any treatment you choose to pursue.
Treatment costs vary based on your specific protocol and are quoted with full transparency during your visit. See full pricing details →
What women ask about menopause.
Is hormone therapy safe? I keep getting mixed messages.
The mixed messaging traces back to the 2002 Women's Health Initiative study, which has since been substantially re-analyzed. Modern evidence — including 2026 NAMS, ACC, and FDA position statements — supports HRT for women under 60 or within 10 years of menopause onset who don't have specific contraindications. The benefit-risk profile is favorable for most women in this window. The 2026 FDA removal of the black box warning reflects this evolved understanding. We discuss the specific evidence with every patient based on their individual situation.
How is menopause diagnosed?
Menopause is technically diagnosed retrospectively — after 12 consecutive months without a menstrual period. Before that point (during perimenopause), diagnosis is clinical, based on symptoms, age, cycle changes, and supporting lab markers (FSH, estradiol, others). We can identify menopausal status clinically even before the 12-month mark when appropriate.
I'm 5+ years past menopause. Is it too late for HRT?
Not necessarily, but the evaluation becomes more nuanced. The "window of opportunity" research suggests starting HRT within 10 years of menopause onset is associated with the most favorable benefit-risk ratio. After that window, HRT can still be appropriate for many women — particularly with transdermal formulations and careful cardiovascular evaluation — but the decision-making is more individualized. We'll evaluate your specific situation rather than apply a blanket rule.
What's the difference between bioidentical and synthetic hormones?
Bioidentical hormones (estradiol, micronized progesterone) are chemically identical in structure to what your ovaries produced. Synthetic versions (like medroxyprogesterone acetate, used in the original WHI study) have different molecular structures. Modern evidence increasingly favors bioidentical formulations, particularly transdermal estradiol and oral micronized progesterone, due to more favorable risk profiles. We use bioidentical hormones in our protocols.
What about delivery method — patches, creams, pellets, oral?
Each has tradeoffs. Transdermal (patches, creams) bypasses first-pass liver metabolism and has a more favorable cardiovascular and clotting profile than oral. Pellets provide steady levels with less frequent administration. Oral is convenient but has higher VTE risk than transdermal. The best choice depends on your specific health profile, lifestyle, and preferences. We discuss options together rather than defaulting to one method.
What if I'm worried about breast cancer?
Breast cancer concern is the most common HRT hesitation, and modern evidence is more reassuring than the original WHI conclusions suggested. Estrogen-alone therapy (for women without a uterus) was actually associated with reduced breast cancer incidence in the WHI. Combined therapy showed a small absolute risk increase that was less concerning than originally portrayed. Family history, genetic factors, and individual risk profiles inform the decision. We discuss your specific risk thoroughly during your evaluation.
How long can I stay on hormone therapy?
There's no arbitrary cutoff. The 2022 NAMS position statement and 2026 European guidelines support continued HRT as long as benefits exceed risks for the individual woman. Some women stay on HRT long-term because the symptom relief and protective effects (bone, cognitive, cardiovascular) are significant. Others taper off when their natural transition stabilizes. Your protocol is regularly re-evaluated.
What about non-hormonal options?
For women who can't or don't want HRT, options include FDA-approved fezolinetant (a neurokinin 3 receptor antagonist) for vasomotor symptoms, certain SSRIs/SNRIs at low doses for hot flashes and mood, gabapentin for hot flashes, and lifestyle interventions including specific exercise, nutrition, and sleep protocols. We'll discuss alternatives if HRT isn't appropriate or preferred for you.
Why does testosterone matter for women?
Testosterone affects libido, energy, mood, muscle mass, bone density, and cognitive function in women — at lower levels than men, but meaningfully. Many menopausal women have low testosterone alongside declining estrogen, and treating it alongside other hormones often produces noticeably better outcomes than estrogen alone. Most clinics overlook testosterone in women entirely. We don't.
Do you offer telehealth?
Yes, in Colorado, Arizona, California, and Washington. Telehealth works well for follow-ups and dose adjustments once you're established. We typically prefer the initial comprehensive intake in person if you're in driving distance to our Centennial or Alamosa locations — a real exam adds value. Labs are drawn at any local Quest or LabCorp.
How much does menopause treatment cost?
The comprehensive intake is $495 (includes lab draw, panel, and provider visit). Ongoing hormone therapy costs vary by protocol — pellets, patches, creams, and oral formulations have different cost structures. We provide a clear, written quote during your visit. We're cash-pay but accept HSA/FSA, and we offer financing through CareCredit and Cherry. See full pricing →
What if I had breast cancer in the past — can I still consider HRT?
The blanket "no HRT after breast cancer" position has softened in recent years for many cases. Vaginal estrogen for genitourinary symptoms is increasingly considered acceptable for breast cancer survivors after careful evaluation. Systemic HRT decisions in this population are individualized, considering tumor type, time since treatment, current health, symptom severity, and quality of life. We coordinate carefully with oncology when relevant.
You don't have to just deal with it.
Comprehensive labs. Modern evidence-based treatment. A protocol designed around your biology and your life — not a one-size-fits-all approach.
Centennial / Denver
7354 S Alton Way, Suite 102
Centennial, CO 80112
Mon–Fri · 9 AM – 5 PM
Alamosa · San Luis Valley
315 Edison Ave, Suite B
Alamosa, CO 81101
Mon–Fri · 9 AM – 5 PM
Telehealth
Colorado · Arizona · California · Washington
Full evaluation via video visit
Labs at nearby Quest or LabCorp